IntroductionThe aim of the work was to analyze the impact of selected factors on the
incidence of seroma formation in breast cancer patients undergoing
mastectomy.Material and methodsOne hundred and fifty breast cancer patients were prospectively enrolled in
the study. All patients had mastectomy performed using the same operative
technique with electrocoagulation. The amount of seroma formed after surgery
and its duration were correlated with selected demographic, clinical and
pathological parameters.ResultsThe cumulative total seroma volume collected by the end of treatment was
higher and the overall time of seroma treatment was longer in patients over
the age of 60 years (p = 0.001 and p =
0.001 respectively). Duration of seroma was significantly longer in obese
patients (p = 0.036). The cumulative total seroma volume
collected by the end of treatment was higher and the overall time of seroma
treatment was longer in patients who had over 130 ml of lymph drained during
the first 24 postoperative hours (p < 0.001 and
p = 0.001 respectively). Additionally, longer duration
of seroma was observed in patients with pathological stage I and II
according to TNM-UICC (p = 0.042) and in patients with
≥ 1200 g weight resected of mammary gland (p =
0.05).ConclusionsAge and obesity are important prognostic factors influencing seroma formation
in breast cancer patients undergoing mastectomy. The amount of lymph formed
during first postoperative day may have predictive value in assessing
cumulative total seroma volume collected during treatment and its overall
duration.
SummaryBackgroundIn this prospective, randomized, placebo-controlled, double-blinded clinical trial we tested the hypothesis that preemptive analgesia with bupivacaine applied in the area of the surgical incision in patients undergoing mastectomy for breast cancer would reduce post-operative acute pain and would reduce the amount of analgesics used during surgery and in the post-operative period.Material/MethodsParticipants were assigned into 1 of 2 groups – with bupivacaine applied in the area of surgical incision or with placebo. We assessed the intraoperative consumption of fentanyl, the postoperative consumption of morphine delivered using a PCA method, and the subjective pain intensity according to VAS score reported by patients in the early post-operative period.ResultsOut of 121 consecutive cases qualified for mastectomy, 112 women were allocated randomly to 1 of 2 groups – group A (bupivacaine) and group B (placebo). The final study group comprised 106 breast cancer cases. Between the groups, a statistically significant difference was observed with respect to: lower fentanyl consumption during surgery (p=0.011), lower morphine (delivered by means of a PCA) consumption between the 4–12th postoperative hours (p=0.02) and significantly lower pain intensity assessed according to VAS score at the 4th and 12th hours after surgery (p=0.004 and p=0.02 respectively) for the group A patients.ConclusionsPreemptive analgesia application in the form of infiltration of the area of planned surgical incisions with bupivacaine in breast cancer patients undergoing mastectomy decreases post-operative pain sensation, limits the amount of fentanyl used during surgery, and reduces the demand for opiates in the hours soon after surgery.
Invasive mucormycosis in immunocompromised children is a life-threatening fungal infection. We report a case of a 7-year-old girl treated for acute lymphoblastic leukaemia complicated by disseminated mucormycosis during induction therapy. Microscopic examination of surgically removed lung tissue revealed wide, pauci-septate hyphae suggesting a Mucorales infection. This diagnosis was confirmed immunohistochemically and by PCR analysis followed by a final identification of Cunninghamella sp. The patient was treated successfully with surgical debridement and antifungal combination therapy with amphotericin B, caspofungin and isavuconazole. The use of isavuconazole in a child was not previously reported. Additionally, case reports concerning pulmonary mucormycoses in paediatric population published after 2010 were reviewed. Nineteen out of 26 identified patients suffered from haematological diseases. Reported mortality reached 38.5%. By the fact of rising morbidity, unsatisfactory results of treatment and remaining high mortality of mucormycoses in immunocompromised patients, new therapeutic options are warrant. Isavuconazole, with its broad-spectrum activity, good safety profile and favourable pharmacokinetics, is a promising drug. However, further studies are necessary to confirm positive impact of isavuconazole on mucormycosis treatment in children.
Implementation of a CCR program improves physical capacity, exercise tolerance, and quality of life and reduces depressive symptoms in patients late after surgical correction of CHD. Introduction of such programs seems reasonable as a supplement to the holistic care for GUCH patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.